ESMO – European Society for Medical Oncology shared on LinkedIn:
“The multimodal AI framework, DANTES, combining Medical Imaging from CT scans and PET scans with clinical information was tested on data from patients with advanced NSCLC treated with immunotherapy enrolled in the APOLLO11 consortium.
In an external cohort of 130 patients, adding PET scan image data to clinical data provided the most accurate prediction of 6-month Progression Free Survival.
Julien Vibert discusses the findings and gives his thoughts on the use of AI for outcome prediction and Precision Oncology.”

Read the full article: A multimodal AI model shows promise in predicting survival in non-small cell lung cancer.
You can also read: Humaid Al-Shamsi: Nexomic Brings the Largest Team Representation to ESMO AI 2026.
